Clinical Trial Update: Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated switching from an SSRI to tiagabine (Gabitril) to alleviate SSRI-induced sexual dysfunction in patients with anxiety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Sexual Dysfunction

Drugs mentioned

• Gabitril (tiagabine)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Anxiety, Sexual Dysfunction | Phase 4 | Status: COMPLETED